Audiological and Electrophysiological Changes in Patients with Vitiligo
- PMID: 27833865
- PMCID: PMC5083641
- DOI: 10.1007/s12070-015-0889-5
Audiological and Electrophysiological Changes in Patients with Vitiligo
Abstract
The study was conducted to evaluate the audiological and electrophysiological findings in patients with Vitiligo and to compare the findings with otologically and audiologically normal controls. Study group included 50 subjects (25 Males, 25 Females) with Vitiligo (Mean age-27.4 years) and control group contained 40 age-matched normal hearing subjects. Pure tone audiometry (PTA) with extended high frequency audiometry, Otoacoustic emissions (OAEs), Tympanometry, Auditory brainstem responses (ABR) and Middle latency responses (MLR) were conducted in all subjects. Comparison of the study group with the control group showed statistically significant differences (p < 0.05) on PTA, in Transient otoacoustic emissions (TOAEs) at 1, 2, 3, 4 kHz and in distortion product otoacoustic emissions (DPOAEs) at 357, 499, 704, 1003 Hz. On ABR, statistically significant differences were observed between the groups in wave I (p < 0.01) in both ears, wave V (p < 0.05) in left ear and on interpeak latency of I-III (p < 0.01, p < 0.05), III-V (p < 0.01 in left ear) and I-V (p < 0.01, p < 0.05) in left and right ears respectively. When patients with localized vitiligo were compared with generalized vitiligo, the SNR of TOAEs was highly significant in both ears at 2 KHz (p < 0.05), 3 kHz (p < 0.01) and 4 kHz (p < 0.05). PTA average of 2 KHz, 4 and 8 kHz (PTA2) showed a significant difference (p < 0.01) when localized vitiligo was compared to generalized vitiligo. Results support possible auditory and electrophysiological changes in Vitiligo patients along with decreased cochlear function.
Keywords: ABR; MLR; Melanocytes; OAEs; Pure tone audiometry; Vitiligo.
Conflict of interest statement
Compliance with Ethical Standards Ethical Standards All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study. Conflict of interest No conflict of interest as no funding was received from any agency. Richa Arya, Sanjay Munjal, Naresh Kumar Panda and Davinder Prasad declares that he/she has no conflict of interest.
References
-
- Hann SK, Nordlund JJ. Definition of vitiligo. In: Hann SK, Nordlund JJ, editors. Vitiligo: a monograph of the basic and clinical science. Oxford: Blackwell Science Ltd.; 2000. pp. 3–5.
-
- Ortonne JP, Bahodoran P, Fitz Patrick TB, Mosher DB, Hori Y. Hypomelanoses and Hypermelanoses. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick’s dermatology in general medicine. 6. New York: Mc Graw Hill; 2003. pp. 839–847.
-
- Lomoreux L, Boissy RE. Animal models. In: Hann SK, Nordlund JJ, editors. Vitiligo: a monograph of the basic and clinical science. Oxford: Blackwell Science Ltd.; 2000. pp. 281–295.
LinkOut - more resources
Full Text Sources
Other Literature Sources